Millennium Management »

Summit Therapeutics shares owned by Millennium Management

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Millennium Management from 13F filings

Historical chart of Millennium Management investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Millennium Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Millennium Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $15M 1.9M 7.80
2023-06-30 $293k 117k 2.51
2023-03-31 $1.6M 904k 1.75
2022-06-30 $457k 458k 1.00
2021-03-31 $2.0M 346k 5.87
2020-12-31 $74k 16k 4.68

More positions owned by Millennium Management

Ishares Tr Russell 2000 Etf Put Option (IWM)
NVIDIA Corporation Put Option (NVDA)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation Put Option (MSFT)
Amazon Put Option (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Tesla Motors (TSLA)
Broadcom Put Option (AVGO)
Ishares Tr Msci Emg Mkt Etf (EEM)
Advanced Micro Devices Put Option (AMD)
Merck & Co Call Option (MRK)

View all positions for Millennium Management

Top funds holding Summit Therapeutics

Baker Bros. Advisors
Vanguard Group
FMR
BlackRock
State Street Corporation
Geode Capital Management
T. Rowe Price Associates
Millennium Management
Caption Management
Northern Trust
Balyasny Asset Management
Frigate Ventures
Charles Schwab Investment Management
Susquehanna International
Rafferty Asset Management

View all funds holding Summit Therapeutics